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Abstract
During bleeding the skin is subjected to oxidative insults from free heme and radicals, generated from extracellular
hemoglobin. The lipocalin a1-microglobulin (A1M) was recently shown to have reductase properties, reducing heme-
proteins and other substrates, and to scavenge heme and radicals. We investigated the expression and localization of A1M
in skin and the possible role of A1M in the protection of skin tissue from damage induced by heme and reactive oxygen
species. Skin explants, keratinocyte cultures and purified collagen I were exposed to heme, reactive oxygen species, and/or
A1M and investigated by biochemical methods and electron microscopy. The results demonstrate that A1M is localized
ubiquitously in the dermal and epidermal layers, and that the A1M-gene is expressed in keratinocytes and up-regulated
after exposure to heme and reactive oxygen species. A1M inhibited the heme- and reactive oxygen species-induced
ultrastructural damage, up-regulation of antioxidation and cell cycle regulatory genes, and protein carbonyl formation in
skin and keratinocytes. Finally, A1M bound to purified collagen I (Kd=0.96610
26 M) and could inhibit and repair the
destruction of collagen fibrils by heme and reactive oxygen species. The results suggest that A1M may have a physiological
role in protection of skin cells and matrix against oxidative damage following bleeding.
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Introduction
The skin is continuously subjected to oxidative stress from both
exogenous and endogenous sources. Reactive oxygen species (ROS)
are generated from mitochondrial metabolism in dermal cells and
enzymatic production by phagocytic and non-phagocytic NADPH-
oxidases, but also from exposure of skin to ionizing radiation, UV-
light irradiation, environmental toxins, chemotherapeutic com-
pounds, etc. [1,2,3,4]. ROS include hydrogen peroxide (H2O2)a n d
the hydroxyl and superoxide radicals, which induce oxidative stress
by oxidative reactions with cellular and extracellular molecular
components. Normally, ROS and other oxidants are counteracted
by antioxidants including the high-molecular weight enzymes
superoxide dismutase (SOD), catalase, glutathione peroxidases
(GPx) and the low-molecular weight non-enzymatic compounds
glutathione (GSH), vitamin C and E [5,6,7,8]. The molecular
damage mechanisms of oxidative stress in skin are not fully known,
but increased oxidative stress and insufficient antioxidant defenses
are believed to play an important role in many skin diseases [9].
In conditions characterized by capillary leakage in the skin, such
as during wounding, extra-vascular accumulation of red blood
cells represents an oxidative threat because subsequent hemolysis
leads to a massive release of free hemoglobin (Hb). Hb consists of
four globin chains each carrying an iron-containing heme-group
that is responsible for the oxygen-binding capacity of the molecule
[10]. Free Hb is a strong pro-oxidant because it undergoes
spontaneous auto-oxidation reactions generating ROS, free heme
and free iron [11]. In addition, the latter two compounds are
further sources of ROS and strong inducers of oxidative stress
[12,13].
Uncontrolled, excessive oxidative stress is believed to be a major
factor during impaired wound repair [9]. We recently suggested a
protective role of the antioxidant and heme- and radical scavenger
a1-microglobulin (A1M) in chronic leg skin-wounds [14]. A1M is a
ubiquitous low molecular weight (26 kDa) plasma and tissue
protein [15,16] mainly synthesized in liver [17,18] but also, in less
amounts, in peripheral organs such as blood cells, pancreas and
kidney. From the liver cells, it is secreted to the blood stream
where it is found in a free form (,1 mM) and as high-molecular
weight complexes with IgA, albumin and prothrombin (,1 mM)
[19,20]. It is rapidly distributed to all tissues where it is transported
from the blood vessels to the extravascular compartments [21].
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truncated variant (t-A1M), lacking the C-terminal tetrapeptide
LIPR, is formed in a reaction with free Hb [22]. A1M is a
reductase [24], a multispecific scavenger of small organic radicals
[25] and has antioxidant properties [26]. An increased synthesis in
liver and blood cells is induced by cell-free Hb and ROS [27].
A1M is associated to both cells and matrix components in the
epidermal and dermal layers of the skin [14,28,29]. In this work
we have investigated the expression and localization of A1M in
skin and keratinocytes, and the protective effects of A1M on ex vivo
skin explants, keratinocyte cultures and purified collagen exposed
to free heme and ROS.
Results
Localization and expression of A1M in skin and
keratinocytes
A1M is ubiquitously localized in healthy skin as revealed by
immunohistochemical staining of paraffin-embedded skin tissue
sections (Fig 1A, B). Pericellular and cytosolic staining with anti-
A1M was seen in the epidermal keratinocytes, slightly less intense
in the deep layers. A global staining was seen in the dermis, and
was especially pronounced in fibers, in the basement membranes
around blood vessels, and in the epidermal-dermal junction.
Expression of the A1M gene in skin and in primary keratinocyte
cultures obtained from skin was shown by real time PCR and
radioimmunoassay (RIA) (Fig 1C, D and E, Table 1). The
expression was significantly up-regulated after incubation of the
skin explants or keratinocyte cultures with heme or hydroxyl
radical-producing Fenton reaction-mixture for 20 hours. Further-
more, the synthesis of the A1M-protein was increased after
incubating keratinocytes with heme for 3-20 hours (Fig 1E).
A1M inhibits heme- and ROS-induced oxidative damage
in skin and keratinocytes
Skin and keratinocytes were incubated in vitro with heme and the
Fenton reaction-mix, in the presence or absence of A1M, and the
response was analyzed using molecular biological and biochemical
parameters (Fig 2) and transmission electron microscopy (EM)
(Fig 3).
In skin, both heme (20 mM) and the Fenton reaction-mix
(20 mM), incubated with the explants for 20 hours, induced a
significantly increased expression of the cell cycle regulatory gene
p21, and heme oxygenase-1 (HO-1), a heme-degrading enzyme
Figure 1. Histochemical distribution and expression of A1M. A. The sections (x10) were stained for A1M using monoclonal mouse anti-A1M
BN11.10 (10 mg/mL) followed by peroxidase/diaminobenzidine tetrahydrochloride incubation as described in Materials and Methods. B. Control
sections (x10) incubated without primary antibody. C, D and E. Human skin explants (161062 mm) or primary keratinocytes were cultured in
serum-free medium as described in Materials and Methods. C. Skin explants were incubated with 20 mM (NH4)Fe(SO4)2+200 mM ascorbate+40 mM
H2O2 (=Fenton; white bar) or 20 mM heme (grey) for a period of 20 hours. D. Keratinocytes were incubated with 20 mM heme for a period of 3
(white) or 20 (grey) hours. Total RNA was extracted from homogenized cells, cDNA was prepared using reverse transcription and expression of A1M
was analyzed using real-time PCR as described in Materials and Methods. A1M threshold cycle values were normalized against G3DPH and DDCt was
calculated by normalizing against control samples which were incubated with buffer only for the same time-periods. Consequently, DDCt-values of all
controls are zero and correspond to the baseline. E. Keratinocytes were cultured in serum-free medium as described in Materials and Methods. The
cells were then incubated with 20 mM heme for a period of 3 (white) or 20 (grey) hours. The cells were homogenized and the A1M concentration was
determined using RIA as described in Materials and Methods. The total protein concentrations were determined with Bradford protein assay as
described in Materials and Methods. Results are from triplicate experiments and are presented as mean 6 SEM. Statistical comparison with control
cultures was made using Students t test. * P,0.05 ** P,0.01, *** P,0.001.
doi:10.1371/journal.pone.0027505.g001
Protection of Skin from Oxidative Damage by A1M
PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27505shown to be up-regulated by ROS and oxidants [30](Fig 2A,
Table 1). The increased expression of these two genes was
inhibited by the addition of 10 mM A1M, down to below the levels
of un-stimulated skin. In keratinocytes, 20 mM heme, incubated
for 3 or 20 hours, induced a significantly increased expression of
the HO-1 gene, and this was also significantly lower in the
presence of 10 mM A1M (Fig 2B). Addition of 10 mM A1M alone
significantly down-regulated the expression of p21 in skin explants
(Fig 2A) but had no effect on the expression of HO-1-gene in skin
or keratinocytes (Fig 2A and B), indicating different regulation
mechanisms of these two genes. Finally, a significantly increased
cell-death (Fig 2C) and formation of the oxidative marker protein
carbonyl groups (Fig 2D) were observed. These responses were
significantly lower in the presence of 10 mM A1M (Fig 2C-D).
Indeed, after 20 hours, the cell-death of the keratinocytes was
almost 100% in the presence of heme, but suppressed down to
15% by addition of A1M (Fig 2C).
To further analyze the protection by A1M, EM was performed
on skin explants (Fig 3A–C, left and middle columns) and cultured
keratinocytes (Fig 3A–C, right column). Extensive destructive
effects were seen by heme both in skin and keratinocytes, (Fig 3B),
i.e. vast formation of vacuoles, formation of intercellular gaps,
ruffling and rupture of plasma membrane and structural des-
organization of keratin fibers. These effects were counteracted by
the addition of A1M (Fig 3C). Furthermore, heme incubation
resulted in a loss of dense structures in the extracellular matrix
architecture (Fig 3B, left). This effect was reversed by addition of
A1M (Fig 3C, left). Incubation with the Fenton reaction-mix
induced similar effects on skin and keratinocytes, and these were
also counteracted by A1M (not shown). The results suggest that
A1M protects and preserves cellular structures otherwise damaged
and disintegrated by heme and ROS.
EM of tissue specimens, containing exogenously added A1M
and incubated with gold-labeled anti-A1M, showed a localization
of A1M to the plasma membrane, ER and nuclear membrane
(Fig 3D). The anti-A1M was not associated with caveoli (Fig 3D,
right) suggesting a non-endocytotic uptake of the protein by the
keratinocytes.
A1M inhibits and reverses heme- and ROS-induced
oxidation of collagen I in vitro
The results obtained by immunohistochemistry and EM suggest
a localization of A1M to collagen fibers and a protective effect of
the protein in the extracellular matrix. Therefore, the effects of
heme and ROS and the protective properties of A1M on purified
collagen I were investigated. Heme induced carbonyl group
formation on collagen monomers immobilized to microtiter plates
and this was completely inhibited by addition of A1M (Fig 4A, left)
in a dose-dependent manner. A1M was also pre-incubated with
collagen and non-bound A1M was removed by washing before
addition of heme. As shown in Fig 4A (right), the carbonyl
formation on collagen was inhibited by A1M suggesting that the
bound A1M was sufficient to achieve the inhibition.
As shown in Fig 4B the exposure of collagen to 0.16 mM H2O2
resulted in disappearance of the collagen bands, suggesting an
extensive degradation of the collagen. The degradation was
inhibited by addition of 3 or 10 mM A1M but not by the lipocalin
a1-acid glycoprotein (not shown). Exposure of collagen to 1 mM
H2O2 also induced formation of carbonyl groups in the microtiter
plate assay, and this was inhibited by addition of 5 or 10 mM A1M
in a dose-dependent manner (Fig 4C, left). Pre-incubation of
collagen with A1M followed by washing before addition of H2O2,
also resulted in a dose-dependent inhibition (Fig 4C, right)
suggesting that A1M bound to collagen was sufficient to achieve
the inhibition.
In most experiments the ELISA absorbance values in the
presence of A1M were even lower than in untreated collagen
(Fig 4A–C). This suggests that A1M may be able to remove pre-
formed oxidation products. To investigate this, collagen was
oxidized on microtiter plates with 50 mM heme and washed before
A1M was added (Fig 4D). A significant decrease of carbonyl
groups was seen after addition of 0.1 mM A1M and was even more
evident after addition of 0.3 and 1 mM A1M. The control
substances, ovalbumin and ascorbate, the latter an antioxidant and
reducing agent, did not have any significant effects at these
concentrations (not shown).
Next, the effects of heme, the Fenton reaction-mix, and A1M
on collagen fibrils, formed in vitro from purified collagen I-
monomers, were examined by EM (Fig 5). Disruption of the
fibrils (Fig 5A) was seen after 24 hours incubation with 20 mM
heme (Fig 5B) or Fenton reaction-mix (100 mMF e
2+, Fig 5F).
Addition of 10 mM A1M to the incubations with heme (Fig 5C)
or the Fenton reaction-mix (Fig 5G), prevented the destruction.
As seen in Fig 5D and 5H, incubation with 10 mM A1M after the
heme- or Fenton incubation reversed the destructive effects on
the fibril morphology.
Binding of A1M to collagen fibrils
A1M bound in vitro to the collagen fibrils, as revealed by EM
using gold-labeled anti-A1M antibodies (Fig 5E). A specific
binding of
125I-labelled A1M was also demonstrated and
quantified after coating of microtiter plates with collagen I
monomers (Fig 6). Using Scatchard analysis, the binding strength
was estimated to 0.96610
26 M
21.
Discussion
Immunohistochemistry revealed a broad distribution of A1M in
the epidermal and dermal layers of the skin. The protein has
previously been found in normal skin, but only at specific
Table 1. Ct-values of A1M, HO-1 and p21 mRNA expression.
A1M HO-1 p21
Skin Normalized Cycle threshold (Ct) value
Control 29.5460.42 30.9060.19 33.2060.00
20 mM heme 28.1560.15
*1 26.2160.08
***1 30.6860.10
***1
20 mM Fenton 27.9360.00
***1 28.4760.23
**1 32.2960.01
***1
20 mM heme+10 mM
A1M
- 33.5760.04
***2 33.6060.00
***2
20 mM Fenton+10 mM
A1M
- 31.1460.03
***2 33.8060.30
***2
Keratinocytes Normalized Cycle threshold (Ct) value
Control 34.4360.27 25.0160.04 -
20 mM heme 29.0160.04
**1 17.4060.03
***1 -
20 mM heme+10 mM
A1M
- 19.2760.03
***2 -
cDNA was prepared using reverse transcription and quantified by real-time PCR
as described in Materials and Methods. A1M, HO-1 and p21 threshold cycle
values were normalized against G3DPH. Results are from triplicate experiments
and are presented as mean 6 SEM. Statistical comparison between groups was
made using Students t test. * P,0.05, ** P,0.01, *** P,0.001.
1 Statistical
comparison vs. control,
2 statistical comparison vs heme or Fenton-reaction. The
Ct-values were also used to calculate DDCt-values and these are shown in
Figures 1 and 2.
doi:10.1371/journal.pone.0027505.t001
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occasional dermal fibrous structures [29] and in the basement
membranes around blood-vessels in skin from chronic leg ulcers
[22]. The findings here, however, are the first evidence of an
extensive presence of A1M in both epidermal and dermal layers of
normal skin (Fig 1). Moreover, a constitutive expression of A1M
was demonstrated in epidermal keratinocytes. Cytoplasmic
staining of cells in the epidermis by anti-A1M was apparent in
the immunohistochemical sections (Fig 1). The expression of the
A1M-gene and production of the A1M-protein in cultured
keratinocytes could be confirmed by real-time PCR and RIA
(Table 1, Fig 1). The results indicate a similar level of A1M-
synthesis as previously reported in cells of myeloid and erythroid
origin [27] but a lower level than in the liver and cells of hepatic
origin [18,27,31]. These results thus corroborate the view of A1M
as synthesized constitutively at a high level in the liver and at a
lower level in most other organs.
The expression of A1M in keratinocytes was up-regulated by
exposure to free heme or iron-generated hydroxyl radicals (Fig 1).
We therefore hypothesized that the increased production of A1M
would lead to protection of the keratinocyte cultures and skin
against oxidative damage caused by heme and ROS. The results
reported here support this hypothesis. Thus, addition of A1M
inhibited the heme- and ROS-induced cell-death, formation of
carbonyl groups and up-regulation of cell cycle arrest (p21) and
antioxidation (HO-1) genes in skin and keratinocytes. A similar
up-regulation of A1M and protective effects against Hb-, heme-
and ROS-induced oxidative damage was reported previously in
hepatoma and blood cell-lines [26,27].
EM analysis of skin tissue and keratinocyte cultures after
incubation with heme, revealed signs of apoptosis (vacuole
formation), plasma membrane rupture, destruction of the structure
of the endoplasmatic reticulum and nuclear membrane, and a
reduction of the keratin fibers in number and thickness. Similar
effects were seen when exposing skin and keratinocytes to the
Fenton reaction (not shown). The ultrastructural tissue damage
seen here resemble the damage of trophoblasts described after in
vitro perfusion of placentas with Hb [32], suggesting similar
mechanisms for the oxidative destruction of skin and placenta
ultrastructure by Hb, free heme or iron. In the same placenta
perfusion study [32], A1M inhibited the Hb-induced cell- and
matrix damage as seen by EM analysis, and similar results were
obtained in this study, i.e. A1M inhibited the heme- and iron-
induced morphological destruction of the skin and keratinocytes.
Furthermore, A1M was found to be associated with most of the
organelles through-out the cell, i.e. localized to the plasma
membrane, endoplasmatic reticulum, Golgi, mitochondria and
nuclear membrane by immunostaining of EM-sections with anti-
Figure 2. A1M inhibits heme- and ROS-induced oxidation in skin and keratinocytes. Human skin explants (161062 mm) or primary
keratinocytes were cultured in serum-free medium as described in Materials and Methods. A. Skin explants were incubated with 20 mM
(NH4)Fe(SO4)2+200 mM ascorbate+40 mMH 2O2 (=Fenton), 20 mM heme with or without 10 mM A1M, or 10 mM A1M alone, for a period of 20 hours. B.
Keratinocytes were incubated with 20 mM heme with or without 10 mM A1M, or 10 mM A1M alone, for a period of 3 (white) or 20 (grey) hours. Total
RNA was extracted from homogenized cells; cDNA was prepared using reverse transcription and quantified by real-time PCR as described in Materials
and Methods. p21 and HO-1 threshold cycle values were normalized against G3DPH and DDCt were calculated by normalizing against non-exposed
samples. Consequently, DDCt-values of all controls are zero and correspond to the baseline. C and D. Keratinocytes were cultured in serum-free
medium as described in Materials and Methods. The cells were then incubated with 20 mM heme with or without 10 mM A1M for a period of 3 (white)
or 20 (grey) hours. C. The amount of LDH present in the culture medium was measured using CytoTox 96H Non-Radioactive Cytotoxicity Assay as
described in Materials and Methods. D. The cells were harvested and the protein carbonyl group concentrations were measured by ELISA as
described in Materials and Methods. Results are from triplicate experiments and are presented as mean 6 SEM. Statistical comparison between
groups was made using Students t test. * P,0.05 ** P,0.01, *** P,0.001.
1 Statistical comparison vs. control,
2 statistical comparison with heme or
Fenton treatment.
doi:10.1371/journal.pone.0027505.g002
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contribute to the efficient cytosolic protective effects of the protein.
The immunohistochemical analysis also suggests a localization
of A1M to collagen fibers in the extracellular matrix (Fig 1),
supporting previous reports on skin and placenta [28]. Here, we
demonstrate a direct binding between purified A1M and collagen
I fibrils, using EM and binding assays, with an affinity in the
physiological range (Figs 5E and 6). The results also demonstrated
protective effects of A1M against oxidative damage of collagen
fibers. The carbonyl group formation and fibrillar destruction
induced by free heme and iron were inhibited by A1M. The EM-
analysis also showed that A1M could protect extracellular matrix
structures ex vivo, i.e. addition of A1M to skin explants exposed to
heme and iron reversed the disintegration of extracellular matrix
(Fig 3A-C, left panels). These results agree well with the previous
report [32] that perfusion of placentas with Hb induced a dramatic
loss of striated fibrils in the extracellular matrix, which was
counteracted by A1M. Interestingly, perfusion with A1M also
induced an up-regulation of collagen-, elastin-, and other genes of
extracellular matrix components. Thus, taken together, the
localization of A1M to matrix fibers, binding to collagen fibrils,
inhibition of oxidative damage and up-regulation of collagen
genes, suggest an important role of A1M in collagen homeostasis.
A1M has been shown to have a reductase activity [24,25], as
well as heme- and radical-binding properties [22,23,25] but the
precise molecular mechanisms of its protective activities are not yet
known and needs to be investigated in more detail. A unifying
model of the protection mechanism of A1M may be that the
molecule acts as a ‘‘radical sink’’. According to this model, which
was proposed i detail previously [25], each A1M-molecule can
eliminate at least 8-9 radicals by a semi-catalytic covalent trapping
mechanism that involves the reducing capacity of the Cys34 side-
Figure 3. Human normal skin (Left and middle panel) was dissected into 161062 mm pieces and placed in Keratinocyte SFM
culture medium. Human primary keratinocytes were cultured in Keratinocyte SFM medium (Right panel). Skin and keratinocytes were then
incubated for 20 hours at RT with buffer only (A), with 20 mM heme (B) or with 20 mM heme and 10 mM A1M (C, D). Immunolabeling of thin sections
with gold-labeled anti-A1M were performed (D). The samples were prepared as described in Materials and Methods and observed in a Jeol JEM 1230
electron microscope, operated at 80 kV accelerating voltage. Images were recorded with a Gatan Multiscan 791 charge-coupled device camera. BM=
basement membrane, PM=plasma membrane, NM= nucleus membrane, V= vacuoles, ECM= extracellular matrix, K= keratin, ER= endoplasmatic
reticulum, C= caveoli. Scale bar in C (middle) indicate 2 mm (is applicable for Figure A, B and C, left and middle), in C (right) indicate 1 mm (is
applicable for A, B and C, right) and D (right) indicate 0.2 mm (is applicable for D, left, middle and right).
doi:10.1371/journal.pone.0027505.g003
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and Lys-side chains and Cys34. These side-chains are thus
oxidized to a one-electron radical state and can react with ROS
and radicals in the near environment by covalent binding. The net
result is the reduction of 5-6 radicals plus covalent binding of at
least 3 other radicals to the A1M-molecule. The covalent trapping
continues until the A1M-molecule becomes saturated and is
cleared from the tissues by the blood and subsequent glomerular
filtration in the kidneys. It can thus be speculated that the ROS-
species generated both by the heme-group and by the Fenton-
reaction are eliminated by this mechanism. Thus, in the case of the
heme-group, it may not be the binding of heme-groups per se that
inhibits the oxidative injuries induced by heme, but rather the
scavenging of downstream ROS-species generated by free heme.
This would explain the catalytic action of A1M visavi both heme-
and Fenton-induced oxidative tissue damage, i.e. the higher than
1:1 molar capacity of A1M. We have shown previously that a
mutated form of A1M, lacking the active group of Cys34, is not
capable of reductase or radical scavenging activity [24,25].
According to the protection model discussed here, this mutated
form should not be able to exert any protection against heme- and
Fenton-induced cell and tissue damage, even though it may still
have the heme-binding capacity. We are presently investigating
this hypothesis.
The results indicate that the oxidative modifications on
collagen, measured as carbonyl groups, were reduced by
incubation with A1M. Thus, A1M could not only inhibit the
formation of oxidative modifications but also remove pre-formed
carbonyl groups (Fig 4). This indicates a repair effect of the protein
which also may be an effect of its reductase activity. Moreover, the
results of the EM analysis (Fig 5) show that heme and iron
destroyed the collagen fibrils. Adding A1M reversed the reaction,
i.e. the fibrils were regenerated. Hypothetically, oxidative
modifications of the monomers, induced by heme and Fenton
reaction, may induce a shift of the equilibrium between monomers
and fibrils towards the monomers by preventing their interaction,
whereas A1M, by removing/reducing the oxidative modifications,
thus may promote a shift of the equilibrium back towards fibril
formation.
Many pathological conditions of the skin are associated with an
increased oxidative insult to cells and tissue components. As
discussed above, extravasation of red blood cells and subsequent
hemolysis result in high levels of Hb, heme, iron and free radicals
in chronic leg ulcers. Furthermore, microbial infections and many
other inflammatory conditions, such as atopic dermatitis and
psoriasis are associated with necrotic cell-death and release of free
radical-generating cell-components such as mitochondria and
cytochromes. The protective mechanisms against these destructive
processes are not yet fully understood. The results presented in this
paper suggest that the plasma and tissue protein A1M may have
an important role as an anti-oxidant, protecting both cells and the
extracellular matrix of skin during health and disease.
Figure 4. A1M inhibits and repairs heme- and ROS-induced oxidation of collagen I in vitro. A (Left). Collagen I, coated to microtiter
plates, was incubated with 30 mM heme alone or in the presence of A1M (2, 4, or 8 mM). (Right) Collagen, coated to microtiter plates, was pre-
incubated with 4 or 8 mM A1M and washed before the addition of 30 mM heme. After 4 hours incubation the protein carbonyl group concentration
was measured using ELISA as described in Materials and Methods. B. Collagen (5 mM) was incubated with PBS (lane 1), 160 mMH 2O2 (lane 2), 160 mM
H2O2+10 mM A1M (lane 3), 160 mMH 2O2+3 mM A1M (lane 4) or only 10 mM A1M (lane 5). After 2 hours at 25uC, the samples were separated on 8%
SDS-PAGE and stained with Coomassie Brilliant Blue R-250. C (Left). Collagen, coated to microtiter plates, was incubated for 4 hours with 1 mM H2O2
alone, or a mixture containing 1 mM H2O2 plus 5 mMo r1 0mM A1M. (Right) Collagen, coated to microtiter plates, was pre-incubated with A1M (5 or
10 mM) and washed before the addition of 1 mM H2O2. The protein carbonyl group concentration was measured using ELISA as described in
Materials and Methods. D. Collagen, coated to microtiter plates, was oxidized by incubation with 30 mM heme for 17 h. After washing, 0.1, 0.3 or
1 mM A1M was added, and incubated for 2 hours. The protein carbonyl group concentration was measured by ELISA as described in Materials and
Methods. Statistical comparison between groups was made using Students t test. * P,0.05 ** P,0.01, *** P,0.001.
2 statistical comparison with
heme or Fenton treatment.
doi:10.1371/journal.pone.0027505.g004
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Reagents and proteins
Cell culture media and supplements were purchased from
Invitrogen (Paisley, Scotland, UK). Hemin (Ferriprotoporphyrin
IX chloride) was purchased from Porphyrin Products, Inc. (Logan,
UT, USA) and a 10 mM stock solution prepared by dissolving in
dimethyl sulphoxide (Sigma-Aldrich, St-Louis, MO, USA).
‘‘Heme’’ and ‘‘hemin’’ are sometimes used to designate free
protoporphyrin IX with a bound Fe
2+ or Fe
3+ atom, respectively;
in this article, ‘‘heme’’ is used regardless of the iron oxidation state.
Hydrogen peroxide was bought from Acros Organics (Geel,
Belgium). Ammonium iron (III) sulfate dodecahydrate was from
Merck (Darmstadt, Germany). A mixture of Fe
3+ (10–100 mM),
ascorbate (0.1–1.0 mM) and hydrogen peroxide (20–200 mM) was
used to generate hydroxyl radicals by the Fenton-reaction. In this
manuscript, the concentration of the Fenton reaction-mix will be
referred to as the Fe
3+ concentration. Collagen S (soluble, type I,
from calf skin, 3 mg/mL) was bought from Roche (Mannheim,
Germany). CytoTox96H Non-Radioactive Cytotoxicity Assay was
from Promega (Madison, WI, USA). 2,4-dinitrophenylhydrazine
(DNP-hydrazine) and o-phenylenediamine were from Sigma-
Aldrich). Anti-DNP-keyhole limpet hemocyanin (KLH) was from
Invitrogen. Swine anti-rabbit IgG-horseradish peroxidase (HRP)
was purchased from Dako A/S (Glostrup, Denmark). Recombi-
nant human A1M, containing an N-terminal His-tag, was
expressed in E. coli and purified and refolded as described [33]
with the addition of an ion-exchange chromatography purification
step. This was performed by applying the A1M to a column of
DEAE-Sephadex A-50 (GE Healthcare, Uppsala, Sweden)
equilibrated with the starting buffer (20 mM Tris-HCl, pH 8.0).
A1M was eluted at a flow rate of 1 mL/min using a linear pH
gradient consisting of 250 mL starting buffer in the first chamber
and 250 mL elution buffer (20 mM Tris-HCl, 0.2 M NaCl, pH
8.0) in the second. Absorbance at 280 nm of eluted fractions was
read and fractions containing pure A1M were pooled and
concentrated. Goat antibodies were prepared against human
urinary A1M using the procedure described [34]. Monoclonal
Figure 5. A1M inhibits destruction of collagen fibrils. Collagen was incubated with buffer for 24 hours at RT to allow fibrillation. Fibrils were
then incubated for a second 24-hour period at RT with heme (B,2 0mM), Fenton-reaction mixture (F, 100 mMF e
3+, 1.0 mM ascorbate, 200 mMH 2O2)
or buffer only (A), either with or without A1M (C and G,10 mM). Fibrils incubated without A1M during the second 24 hour period were then
incubated for a third 24 hour period with buffer or 10 mM A1M (D and H). The samples were then adsorbed for 1 min onto carbon-coated grids. To
study binding of A1M to collagen (E), collagen was allowed to form fibrils by incubation with buffer and then incubated with gold-labeled A1M for
1 hour at RT. The samples were analyzed in a Jeol 1200 EX electron microscope operated at 60 kV accelerating voltage. The scale bar indicates 50 nm
in A–D and F-H and100 nm in E.
doi:10.1371/journal.pone.0027505.g005
Figure 6. Binding of A1M to collagen I. Purified collagen I-
monomers were coated to microtiter plates and incubated with
125I-
labelled A1M in the presence of increasing amounts of non-labeled
A1M. After washing, the radioactivity bound to the microtiter plate
walls was plotted against the total concentration of A1M. The binding
displacement-curve is shown with the corresponding Scatchard plot
(insert). The strength of the binding was estimated using Scatchard
analysis, giving a Kd of 0.96610
26 M. Each point represents the mean 6
SEM of three determinations.
doi:10.1371/journal.pone.0027505.g006
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described [35,36].
Cell culture
Human primary keratinocytes (Cambrex Biologics, Karlskoga,
Sweden) were cultured in Keratinocyte SFM medium (Invitrogen,
Paisley, Scotland, UK) containing 100 mg/mL antibiotics and
0.25 mg/mL antimycotics (amphotericin B and FungizoneH). The
cells were incubated at 37uCi n5 %C O 2.2 0mM heme and/or
A1M (10 mM) were added to the cells as indicated in the figure
legends. Culture medium was collected and cells were harvested in
homogenizing buffer (containing 50 mM Tris-HCl, pH 8.0; 2 mM
EDTA; 1% NP40; 1 mg/mL pepstatin, 5 mg/mL antipain; 10 mg/mL
leupeptin) after 3 and 20 hours and analyzed as described below.
Skin
Normal human skin obtained from reduction surgery was
dissected into 161062 mm pieces and two pieces were placed in
each well of a 6-well culture dish containing Keratinocyte SFM
culture medium (containing 100 mg/mL antibiotics). Heme
(20 mM), Fenton reaction-mix (20 mMF e
3+, 0.5 mM ascorbate,
0.1 mM H2O2) and/or A1M (10 mM) were added to the skin
pieces (as indicated in the figure legends), cultured for 5 hours at
37uCi n5 %C O 2 and analyzed using techniques described below.
The skin specimens were surplus tissue from dermatological
surgery, and obtained following written consent using protocols
approved by the ethical committee at Lund-Malmo ¨ University
Hospital (LU 762-02).
Cell viability assay
The concentration of lactate dehydrogenase (LDH) in culture
media was used to estimate the degree of cytolysis induced by
heme. LDH was measured using CytoTox 96H Non-Radioactive
Cytotoxicity Assay from Promega. The analysis was performed
according to the instructions from the manufacturer. Briefly, at the
end-point of all incubations culture medium was harvested and
50 mL was transferred to a 96-well microtiter plate. Fifty
microliters reconstituted substrate mix were added to each well
and the plate was incubated at room temperature (RT), protected
from light. After 30 minutes 50 mL stop solution were added to
each well and absorbance was read at 490 nm using a Wallac
1420 Multilabel Counter (Perkin Elmer Life Sciences, Waltham,
MA, USA). A1M alone had no significant effect on the absorbance
at 490 nm of the reagents.
RNA isolation and real-time PCR
Total RNA was isolated from skin and keratinocytes using the
acid guanidinium phenol chloroform method supplied by QIA-
GEN Sciences (Germantown, MD, USA). The OD ratio (optical
density at 260 nm/280 nm) of RNA was always greater than 1.8.
Reverse transcription was performed on 3 mg total RNA at 42uC
for 60 min in the presence of 0.5 mg oligo(dT)18 primer, 200 U
reverse transcriptase and 20 U RiboLock
TM Ribonuclease inhib-
itor in reaction buffer (RevertAid
TM H Minus First Strand cDNA
Synthesis Kit, Fermentas GMBH, St. Leon-Rot, Germany). Real-
time PCR was then used to quantify the p21, A1M and (HO-1)
mRNA. Raw data were obtained as cycle threshold values (Ct-
values) and are shown in Table 1 after normalization to the Ct-
values of human glyceraldehyde-3-phosphate dehydrogenase
(G3DPH). The DDCt-values shown in the Figures were then
calculated by normalizing against control samples from cells
incubated with buffer only for the same time-periods. A lower Ct-
value corresponds to an increased mRNA-level and is therefore
depicted as an increased DDCt-value, and vice versa. The DDCt-
values of the controls correspond to the baseline and are not
included in the Figures. Primers were designed accordingly: p21
forward primer 59-TGGACCTGTCACTGTCTTGT-39, reverse
primer 59-TCCTGTGGGCGGATTAG-39; A1M forward primer
59-CACTCGTTGGCGGAAAGG-39, reverse primer 59-ACT-
CATCATAGTTGGTGTGGAC-39; HO-1 forward primer 59-
CAACAAAGTGCAAGA TTCTG-39, reverse primer 59-
AAAGCCCTACAGCAACTG-39; G3DPH forward primer 59-
TGGTATCGTGGAAGGACTC-39, reverse primer 59-AGTA-
GAGGCAGGGATGATG-39. The expression was analyzed using
iQ SYBR Green Supermix (Bio-Rad, Hercules, CA, USA).
Amplification was performed at 55uC for 40 cycles in iCycler
Thermal Cycler (Bio-Rad) and data analyzed using iCycler iQ
Optical System Software.
Radioimmunoassay and total protein analysis
Radiolabelling of A1M with
125I was done using the chloramine
T method [37]. Protein-bound iodine was separated from free
iodide by gel-chromatography on a Sephadex G-25 column
(PD10, GE Healthcare, Buckinghamshire, UK). A specific activity
of around 0.1–0.2 MBq/mg protein was obtained. RIA was
performed as described [38]. Briefly, goat antiserum against
human A1M (0.2 mL, dil. 1:6000) was mixed with
125I-labelled
A1M (0.1 mL, approximately 0.05 pg/mL) and samples, or
standard A1M concentrations (0.2 mL). The dilutions were done
in 0.1 M sodium phosphate, pH 7.4+0.1% BSA (RIA-buffer).
After incubating overnight at RT, antibody-bound antigen was
precipitated by adding 0.3 mL bovine serum and 1.6 mL 15%
polyethylene glycol in the RIA-buffer, centrifuged at 2500 xg for
40 min, and the
125I activity of the pellets was measured in a
Wallac Wizard 1470 gamma counter (Perkin Elmer Life Sciences).
Total protein in cell-homogenates was determined by Bradford
protein assay. This assay was performed by adding one mL of
Bradford reagent (containing 4.2 mM Coomassie Brilliant Blue G
(Sigma-Aldrich, St. Louis, MO, USA), 5% (v/v) EtOH, 6% (v/v)
H3PO4 dissolved in H2O) to 100 mL of each sample, and
incubating at room temperature for 5 min before determination
of absorbance at 595 nm using a UV spectrophotometer (Beck-
man DU640; Beckman Instruments, Palo Alto, CA, USA).
Albumin was used as a standard and plotting the absorbance at
595 nm versus protein concentration generated a standard curve.
Determination of protein carbonyl groups in purified
collagen and keratinocyte medium
Purified collagen S was coated overnight at 4uC to microtiter
plates (Nunc Maxitorp, WVR International, Sweden) diluted to
5 mg/ml in 20 mM Tris-HCl, 140 mM NaCl, pH 7.6, washed five
times with PBS+0.1% Tween-20 and incubated with 30 mM heme
or 1 mM H2O2, together with A1M at different concentrations in
PBS +0.1% Tween-20. Alternatively, the collagen-coated wells
were first incubated with A1M at different concentrations in PBS
+0.1% Tween-20, washed and then oxidized with 30 mM heme or
1m M H 2O2. Formation of protein carbonyl groups in the
collagen was then quantified as described [39]. Briefly, 25 mL
samples were mixed with 75 mL 10 mM DNP-hydrazine (solved in
6 M Guanidine hydrochloride, 0.5 M sodium phosphate, pH 3.0)
for 45 minutes at RT. The DNP-hydrazine derivatized samples
were then diluted with PBS and coated on a 96-well microtiter
plate for 2 hours at RT. After rinsing, the plate was incubated with
rabbit anti-DNP-KLH (diluted 1:2000 in PBS, 0.1% BSA, 0.25%
Tween 20) for 2 hours at RT, followed by rinsing and incubation
with swine anti-rabbit IgG-HRP (diluted 1:2000 in the same
buffer) for 1 hour at RT. Finally, the plate was incubated with
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mM Tris-HCl, pH 8.5, 50 mM Na2HPO4,H 2O2) and absorbance
was read at 450 nm, using a Wallac 1420 Multilabel Counter, at
the onset of the reaction until a peak absorbance was obtained.
Protein carbonyl groups in keratinocyte medium was determined
as described [40] by first DNP-derivatizing the medium samples,
and then coating to microtiter plates and assay with anti-DNP-
KLH using the conditions described above.
Transmission electron microscopy (TEM)
For negative staining collagen S (5 mg/mL) was incubated with
buffer (50 mM Tris-HCl, 0.15 M NaCl, pH 7.6) for 24 hours at
RT to allow fibrillation. Fibrils were then incubated for a second
24 hour-period at RT with a Fenton-reaction mixture (100 mM
Fe
3+, 1.0 mM ascorbate, 200 mMH 2O2), heme (20 mM) or buffer
only, either with or without A1M (10 mM). Fibrils incubated
without A1M during the second 24 hour-period were then
incubated for a third 24 hour-period with buffer or 10 mM
A1M. The samples were then adsorbed for 1 min onto carbon-
coated grids, briefly washed with water, and stained with 0.75%
(w/w) uranyl formate. The grids had been rendered hydrophilic by
glow discharge at low pressure in air beforehand. To study binding
of A1M to collagen, 5 mg/mL collagen S was allowed to form
fibrils by incubation with buffer and then incubated with gold-
labeled A1M (4-5 nm) for 1 hour at RT. A1M was labeled with
colloidal gold as previously described (40).
For ultrathin sectioning, purified keratinocytes and skin sections
were fixed for 1 hour at RT and then overnight at 4uC in 2.5%
glutaraldehyde in 0.15 M sodium cacodylate, pH 7.4 (cacodylate
buffer). Samples were then washed with cacodylate buffer and
post-fixed for 1 hour at RT in 1% osmium tetroxide in cacodylate
buffer, dehydrated in a graded series of ethanol, and then
embedded in Epon 812 (SPI Supplies, West Chester, PA, USA)
using acetone as an intermediate solvent. Specimens were
sectioned with a diamond knife into 50–70 nm-thick ultrathin
sections on an LKB ultramicrotome. The ultrathin sections were
stained with uranyl acetate and lead citrate. Specimens were
observed in a JEOL JEM 1230 electron microscope operated at
80 kV accelerating voltage. Images were recorded with a Gatan
Multiscan 791 CCD camera. Keratinocytes (about 1 million cells)
were pelleted by centrifugation and subsequently fixed and
sectioned. Tissue samples were treated in a similar way, except
that the centrifugation step was omitted. Immunolabeling of thin
sections with gold-labeled anti-A1M were performed as described
by Roth [41] with the modification that Aurion-BSA (Aurion,
Wageningen, The Netherlands) was used as a blocking agent.
Samples were finally stained with uranyl acetate and lead citrate
and observed in a Jeol JEM 1230 electron microscope, operated at
80 kV accelerating voltage. Images were recorded with a Gatan
Multiscan 791 charge-coupled device camera.
Collagen degradation analysis
Collagen, 5 mM, was incubated with H2O2 (0.15–1 mM), A1M
(0–10 mM), or both, in 50 mM Tris-HCl, 0.15 M NaCl, pH 7.6.
After incubation for 1.5 hour at room temperature (RT), the
samples were separated bySDS-PAGEasdescribed previously[42].
Immunohistochemistry
Immunohistochemistry sections were deparaffinized by routine
procedures and endogenous peroxidase activity was blocked with
3% H2O2 in methanol for 10 minutes. After rinsing in distilled
water, followed by PBS, the slides were subsequently permeabi-
lized with Tween 20 (0.05%) in PBS. Thereafter, sections were
rinsed in PBS. After pre-incubation with normal goat serum (1%)
for 30 min at RT, incubation was performed with primary
antibody (mouse monoclonal anti-A1M BN11.10) diluted to
10 mg/mL in PBS (containing 0.05% Tween 20, 0.2% BSA)
overnight at 41uC. Control sections were incubated in the same
PBS solution without antibody. Antibody detection was performed
with a standard avidin-biotin complex detection system after
which they were developed with 3,3-diaminobenzidine tetrahy-
drochloride as the chromogenic substrate (Vectastain avidin-biotin
complex, Vector Laboratories, Burlingame, California). Sections
were mounted with Pertex (Histolab Products AB, Gothenburg,
Sweden) and examined and photographed (Olympus BHS
photomicrographic system).
Solid Phase Binding Assay
Collagen, diluted to 5 mg/mL in 1% acetic acid +1% NaCl,
100 mL/ well, was coated on 96-well flexible assay plates (Falcon
3912, Beckton Dickinson, Oxnard, CA, USA) by incubation at
4uC overnight. The wells were blocked with 1% BSA in PBS
+0.1% Tween 20 for 1 hour at RT. Unlabeled A1M in 50 mL PBS
+0.05% Tween was added to the wells, followed by 50 mL of the
same buffer containing 50610
3 cpm
125I-labeled A1M and
incubated overnight at 4uC. The wells were washed and the
activity was determined in a Wallac Wizard 1470 gamma counter.
Statistical Analysis
Statistical analysis was performed using Origin 8 software
(Microcal, Northampton, MA, USA). Students t-test was used for
statistical evaluation and was considered significant when P,0.05.
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